D-0265-2023 Class III Ongoing

Recalled by Akorn, Inc. — Gurnee, IL

FDA drug recall D-0265-2023 was initiated by Akorn, Inc. on Jan 30, 2023 and is designated Class III. Reason for recall: Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint. The recall status is ongoing. Affected quantity: 45,117 Bottles.

Recall details

Product Type
Drugs
Report Date
Feb 15, 2023
Initiation Date
Jan 30, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45,117 Bottles

Product description

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Reason for recall

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot: 081031A, Exp 2/28/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0265-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0265-2023. Report a data issue: hello@regdatalab.com.